Literature DB >> 19289604

Folding mechanism of the C-terminal domain of nucleophosmin: residual structure in the denatured state and its pathophysiological significance.

Flavio Scaloni1, Stefano Gianni, Luca Federici, Brunangelo Falini, Maurizio Brunori.   

Abstract

Nucleophosmin (NPM1) is a ubiquitously expressed protein and is one of the most abundant proteins found in the nucleolus. Naturally occurring mutations in the C-terminal domain of nucleophosmin (Cter-NPM1) are found in approximately 30% of patients with acute myeloid leukemia (AML). These mutations cause changes at the C terminus of NPM1 that lead to denaturation of the protein, a critical factor in determining aberrant translocation of NPM1 to the cytosol. Hence, this protein system represents an ideal candidate to investigate the relations between folding and unfolding and disease. Here we report the characterization of the folding and unfolding kinetics of Cter-NPM1. Data reveal that this small helical domain folds via a compact denatured state, displaying a malleable residual structure. Moreover, analysis of folding rate constants measured under different experimental conditions suggests that the existence of a preorganized structure in the denatured state accelerates folding, implying a native-like residual structure. Because a major feature of Cter-NPM1 mutants responsible for AML is a reduction in stability of the protein and thus prevalence of a denatured state even under physiological conditions, our findings may pave the way to further studies with the aim of designing chemicals capable of interacting with the "pathological" mutants to stabilize the native conformation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19289604     DOI: 10.1096/fj.08-128306

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  16 in total

1.  Synergic role of nucleophosmin three-helix bundle and a flanking unstructured tail in the interaction with G-quadruplex DNA.

Authors:  Alessandro Arcovito; Sara Chiarella; Stefano Della Longa; Adele Di Matteo; Carlo Lo Sterzo; Giovanni Luca Scaglione; Luca Federici
Journal:  J Biol Chem       Date:  2014-06-21       Impact factor: 5.157

Review 2.  Nucleophosmin mutations in acute myeloid leukemia: a tale of protein unfolding and mislocalization.

Authors:  Luca Federici; Brunangelo Falini
Journal:  Protein Sci       Date:  2013-03-18       Impact factor: 6.725

3.  Deciphering the folding transition state structure and denatured state properties of nucleophosmin C-terminal domain.

Authors:  Flavio Scaloni; Luca Federici; Maurizio Brunori; Stefano Gianni
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-08       Impact factor: 11.205

4.  Structure of nucleophosmin DNA-binding domain and analysis of its complex with a G-quadruplex sequence from the c-MYC promoter.

Authors:  Angelo Gallo; Carlo Lo Sterzo; Mirko Mori; Adele Di Matteo; Ivano Bertini; Lucia Banci; Maurizio Brunori; Luca Federici
Journal:  J Biol Chem       Date:  2012-06-15       Impact factor: 5.157

5.  Nucleophosmin C-terminal leukemia-associated domain interacts with G-rich quadruplex forming DNA.

Authors:  Luca Federici; Alessandro Arcovito; Giovanni L Scaglione; Flavio Scaloni; Carlo Lo Sterzo; Adele Di Matteo; Brunangelo Falini; Bruno Giardina; Maurizio Brunori
Journal:  J Biol Chem       Date:  2010-09-20       Impact factor: 5.157

Review 6.  Residual structure in unfolded proteins.

Authors:  Bruce E Bowler
Journal:  Curr Opin Struct Biol       Date:  2011-10-04       Impact factor: 6.809

7.  Nucleophosmin, a critical Bax cofactor in ischemia-induced cell death.

Authors:  Zhiyong Wang; Jonathan M Gall; Ramon Bonegio; Andrea Havasi; Katarina Illanes; John H Schwartz; Steven C Borkan
Journal:  Mol Cell Biol       Date:  2013-03-04       Impact factor: 4.272

8.  Salt potentiates methylamine counteraction system to offset the deleterious effects of urea on protein stability and function.

Authors:  Safikur Rahman; Md Tabish Rehman; Laishram R Singh; Marina Warepam; Faizan Ahmad; Tanveer Ali Dar
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

Review 9.  Molecules that target nucleophosmin for cancer treatment: an update.

Authors:  Adele Di Matteo; Mimma Franceschini; Sara Chiarella; Serena Rocchio; Carlo Travaglini-Allocatelli; Luca Federici
Journal:  Oncotarget       Date:  2016-07-12

10.  Nucleophosmin mutations alter its nucleolar localization by impairing G-quadruplex binding at ribosomal DNA.

Authors:  Sara Chiarella; Antonella De Cola; Giovanni Luca Scaglione; Erminia Carletti; Vincenzo Graziano; Daniela Barcaroli; Carlo Lo Sterzo; Adele Di Matteo; Carmine Di Ilio; Brunangelo Falini; Alessandro Arcovito; Vincenzo De Laurenzi; Luca Federici
Journal:  Nucleic Acids Res       Date:  2013-01-16       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.